B Escudier - Annals of Oncology, 2011 - Eur Soc Med Oncology The benefit of cytoreductive nephrectomy in metastatic renal cell carcinoma (mRCC) has been demonstrated in patients treated with interferon [1, 2]. Because of that demonstration, cytoreductive nephrectomy has become the standard of care in most institutions. However, one should ... Cited by 2 - Related articles - All 3 versions
G Cao - Journal of Gastroenterology, 2011 - Springer Major risk factors for hepatocellular carcinoma (HCC) vary by region and population. Chronic infection with hepatitis B virus (HBV) and/or hepatitis C virus (HCV), heavy alcohol intake, aflatoxin exposure, haemochroma- tosis, nonalcoholic fatty liver disease, obesity, diabetes mellitus ... Cited by 1 - Related articles - All 4 versions
CM Kelly, KI Pritchard, M Trudeau… - Annals of …, 2011 - Eur Soc Med Oncology ... Next Section. Abstract. Background: Recent retrospectivestudies have suggested that patients with T1a,bN0M0 human epidermal growth factor receptor 2 (HER2)-positive breast cancer are at a higher risk for recurrence and might benefit from adjuvant trastuzumab. ... Cited by 1 - Related articles - All 2 versions
[PDF] from tcd.ieS Byrne, C Walsh, C Lynch, P Bede… - Journal of Neurology, …, 2011 - jnnp.bmj.com ... fulfilling inclusion criteria were grouped together according to the type of data presented: (1) prospective registry based studies that aim to capture all cases within a given geographic region in order to define incidence and prevalence; (2) retrospectivestudies that attempt to ... Cited by 11 - Related articles - All 9 versions
S Selleng, N Schreier, HG Wollert… - Anesthesia & Analgesia, 2011 - IARS ... 2,3. Two retrospectivestudies 4,5 and a case report 6 suggest that a confirmatory procedure using high-dose heparin can improve diagnostic specificity of the anti-PF4/H enzyme immunoassay (EIA) for HIT. These findings conflict ... Cited by 2 - Related articles - All 4 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
